EUVIMEDOdkrijte EUVIMED
Open access · CC BY-NC 4.0

Meta‐Analysis: Fracture Risk Across the Disease Course of Coeliac Disease

Madeleine N. Mosterd, Ewoud Schuit, Johannes C. F. Ket, Hetty J. Bontkes, Daisy M. A. E. Jonkers, Gerd Bouma, Renate T. de Jongh

Alimentary Pharmacology & Therapeutics · 2026-11-20

DOI: 10.1111/apt.71046 ↗

At a glance

Journal article in Alimentary Pharmacology & Therapeutics, published online on 2026-11-20. Written by Madeleine N. Mosterd and 6 co-authors. 53 references. The full text is freely available (open access, CC BY-NC 4.0).

PovzetekBibliografski podatkiCiteRelated studies

Abstract (original language)

Background

Coeliac disease (CD) is associated with metabolic bone disease and increased fracture risk. However, the magnitude of this risk, its trajectory across the disease course, and variation across clinically relevant subgroups remain incompletely understood.

Aims

To quantify fracture risk in adults with CD and examine variation by fracture type, timing relative to diagnosis, unrecognized disease, sex, and age.

Methods

We conducted an updated systematic review and meta‐analysis of observational studies comparing fracture outcomes in adults with and without CD. MEDLINE (Ovid), Embase, and Web of Science were searched through February 2026, with risk of bias assessed using the Newcastle–Ottawa Scale. Random‐effects meta‐analyses with Hartung–Knapp adjustment were performed separately for prevalent and incident fracture estimates, with prespecified subgroup analyses.

Results

Twenty‐three studies (~50,000 CD patients, 1.7 million controls) were included. CD was associated with an increased risk of incident any fracture (HR 1.51, 95% CI: 1.08–2.12; I 2 = 88.3%), incident major osteoporotic fractures (HR 1.37, 95% CI: 1.26–1.50; I 2 = 0%), incident hip fractures (HR 1.96, 95% CI: 1.27–3.04; I 2 = 36.6%) and prevalent wrist fractures (OR 2.04, 95% CI: 1.05–3.91; I 2 = 78.1%). Prevalent major osteoporotic fracture risk was also increased, though imprecise (OR 2.35, 95% CI: 1.01–5.45; I 2 = 97.3%). Although evidence before diagnosis was inconclusive, elevated risk persisted beyond 10 years post‐diagnosis in large registry‐based cohorts. Evidence for differences by age, sex, or unrecognized disease status was limited.

Conclusion

Coeliac disease is associated with a moderate increase in fracture risk, with the most precise estimate observed for incident major osteoporotic fractures. Persistent excess risk after diagnosis supports individualized rather than universal bone health assessment based on underlying fracture risk.

Cite

APA

Mosterd, M. N., Schuit, E., Ket, J. C. F., Bontkes, H. J., Jonkers, D. M. A. E., Bouma, G., & Jongh, R. T. D. (2026). Meta‐Analysis: Fracture Risk Across the Disease Course of Coeliac Disease. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.71046

Vancouver

Mosterd MN, Schuit E, Ket JCF, Bontkes HJ, Jonkers DMAE, Bouma G, et al. Meta‐Analysis: Fracture Risk Across the Disease Course of Coeliac Disease. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.71046

BibTeX
@article{Mosterd2026,
  author = {Mosterd, Madeleine N. and Schuit, Ewoud and Ket, Johannes C. F. and Bontkes, Hetty J. and Jonkers, Daisy M. A. E. and Bouma, Gerd and Jongh, Renate T. de},
  title = {Meta‐Analysis: Fracture Risk Across the Disease Course of Coeliac Disease},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.71046}
}
Start for free →